HLS Therapeutics, Inc. (HLS.TO)
3.91
-0.08
(-2.00%)
CAD |
TSX |
Sep 18, 16:00
HLS Therapeutics Price : 3.91 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 4.01 | 4.02 | 3.91 | 3.91 | 27494.00 |
| Sep 17, 2026 | 4.05 | 4.05 | 3.99 | 3.99 | 8502.00 |
| Sep 16, 2026 | 4.00 | 4.06 | 4.00 | 4.03 | 1618.00 |
| Sep 15, 2026 | 4.15 | 4.205 | 4.07 | 4.09 | 241861.0 |
| Sep 14, 2026 | 3.90 | 4.18 | 3.90 | 4.15 | 54491.00 |
| Sep 11, 2026 | 3.72 | 3.975 | 3.70 | 3.90 | 144351.0 |
| Sep 10, 2026 | 3.93 | 3.93 | 3.72 | 3.73 | 30665.00 |
| Sep 09, 2026 | 3.75 | 3.86 | 3.73 | 3.75 | 17200.00 |
| Sep 08, 2026 | 3.76 | 3.90 | 3.74 | 3.78 | 16260.00 |
| Sep 04, 2026 | 3.65 | 3.77 | 3.60 | 3.70 | 68582.00 |
| Sep 03, 2026 | 3.70 | 3.70 | 3.58 | 3.60 | 17951.00 |
| Sep 02, 2026 | 3.70 | 3.70 | 3.61 | 3.61 | 8800.00 |
| Sep 01, 2026 | 3.72 | 3.75 | 3.64 | 3.75 | 17400.00 |
| Aug 31, 2026 | 3.70 | 3.79 | 3.68 | 3.75 | 29107.00 |
| Aug 28, 2026 | 3.88 | 3.88 | 3.65 | 3.79 | 52047.00 |
| Aug 27, 2026 | 3.72 | 3.92 | 3.65 | 3.70 | 34900.00 |
| Aug 26, 2026 | 3.70 | 3.84 | 3.65 | 3.65 | 17582.00 |
| Aug 25, 2026 | 3.71 | 3.84 | 3.65 | 3.84 | 36505.00 |
| Aug 24, 2026 | 3.70 | 3.77 | 3.64 | 3.69 | 113781.0 |
| Aug 21, 2026 | 3.92 | 3.92 | 3.56 | 3.75 | 126827.0 |
| Aug 20, 2026 | 3.88 | 3.95 | 3.71 | 3.94 | 59900.00 |
| Aug 19, 2026 | 3.93 | 3.94 | 3.71 | 3.87 | 40704.00 |
| Aug 18, 2026 | 3.97 | 3.97 | 3.76 | 3.90 | 12757.00 |
| Aug 17, 2026 | 3.90 | 3.98 | 3.79 | 3.90 | 567607.0 |
| Aug 14, 2026 | 3.90 | 3.99 | 3.88 | 3.90 | 35655.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bausch Health Cos., Inc. | 7.92 |
| Cipher Pharmaceuticals, Inc. | 14.67 |
| BioSyent, Inc. | 15.73 |
| Revive Therapeutics Ltd. | 0.02 |
| Knight Therapeutics, Inc. | 10.25 |
Price Related Metrics
| PS Ratio | 1.574 |
| Price to Book Value | 1.560 |
| Price to Free Cash Flow | 5.600 |
| Earnings Yield | -9.65% |
| Market Cap | 122.26M |